Ming Fai International Holdings Limited (3828.HK)
HKD 0.82
(1.23%)
HKD 0.82
(1.23%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 772.01 Million HKD | 24.93% |
| 2022 | 617.98 Million HKD | -4.08% |
| 2021 | 644.27 Million HKD | 5.43% |
| 2020 | 611.1 Million HKD | -13.69% |
| 2019 | 708.03 Million HKD | 15.22% |
| 2018 | 614.52 Million HKD | 4.26% |
| 2017 | 589.39 Million HKD | -13.19% |
| 2016 | 678.95 Million HKD | 11.26% |
| 2015 | 610.26 Million HKD | -2.66% |
| 2014 | 626.91 Million HKD | 0.15% |
| 2013 | 625.95 Million HKD | 12.25% |
| 2012 | 557.63 Million HKD | -1.0% |
| 2011 | 563.29 Million HKD | 25.2% |
| 2010 | 449.9 Million HKD | 67.79% |
| 2009 | 268.13 Million HKD | 7.16% |
| 2008 | 250.22 Million HKD | 2.91% |
| 2007 | 243.14 Million HKD | 0.87% |
| 2006 | 241.04 Million HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 668.11 Million HKD | 0.0% |
| 2024 Q1 | 668.11 Million HKD | -13.46% |
| 2023 FY | 772.01 Million HKD | 24.93% |
| 2023 Q1 | 666.88 Million HKD | 7.91% |
| 2023 Q2 | 666.88 Million HKD | 0.0% |
| 2023 Q4 | 772.01 Million HKD | 0.0% |
| 2023 Q3 | 772.01 Million HKD | 15.76% |
| 2022 Q1 | 563.43 Million HKD | -12.55% |
| 2022 Q2 | 563.43 Million HKD | 0.0% |
| 2022 Q3 | 617.98 Million HKD | 9.68% |
| 2022 FY | 617.98 Million HKD | -4.08% |
| 2022 Q4 | 617.98 Million HKD | 0.0% |
| 2021 Q2 | 519.96 Million HKD | 0.0% |
| 2021 FY | 644.27 Million HKD | 5.43% |
| 2021 Q3 | 644.27 Million HKD | 23.91% |
| 2021 Q4 | 644.27 Million HKD | 0.0% |
| 2021 Q1 | 519.96 Million HKD | -14.91% |
| 2020 FY | 611.1 Million HKD | -13.69% |
| 2020 Q4 | 611.1 Million HKD | 0.0% |
| 2020 Q3 | 611.1 Million HKD | 3.22% |
| 2020 Q1 | 592.05 Million HKD | -16.38% |
| 2020 Q2 | 592.05 Million HKD | 0.0% |
| 2019 FY | 708.03 Million HKD | 15.22% |
| 2019 Q4 | 708.03 Million HKD | 0.0% |
| 2019 Q3 | 708.03 Million HKD | 24.02% |
| 2019 Q2 | 570.89 Million HKD | 0.0% |
| 2019 Q1 | 570.89 Million HKD | -7.1% |
| 2018 Q1 | 533.54 Million HKD | -9.47% |
| 2018 Q3 | 604.18 Million HKD | 11.66% |
| 2018 Q4 | 614.52 Million HKD | 1.71% |
| 2018 FY | 614.52 Million HKD | 4.26% |
| 2018 Q2 | 541.08 Million HKD | 1.41% |
| 2017 Q2 | 465.47 Million HKD | 0.59% |
| 2017 Q3 | 586.59 Million HKD | 26.02% |
| 2017 FY | 589.39 Million HKD | -13.19% |
| 2017 Q1 | 462.75 Million HKD | -31.84% |
| 2017 Q4 | 589.39 Million HKD | 0.48% |
| 2016 Q2 | 511.16 Million HKD | 0.45% |
| 2016 FY | 678.95 Million HKD | 11.26% |
| 2016 Q4 | 678.95 Million HKD | 0.39% |
| 2016 Q3 | 676.34 Million HKD | 32.31% |
| 2016 Q1 | 508.89 Million HKD | -16.61% |
| 2015 Q2 | 539.75 Million HKD | 0.0% |
| 2015 Q1 | 539.75 Million HKD | -13.9% |
| 2015 Q4 | 610.26 Million HKD | 0.0% |
| 2015 FY | 610.26 Million HKD | -2.66% |
| 2015 Q3 | 610.26 Million HKD | 13.06% |
| 2014 Q2 | 559.2 Million HKD | 0.0% |
| 2014 Q1 | 559.2 Million HKD | -10.66% |
| 2014 Q4 | 626.91 Million HKD | 0.0% |
| 2014 FY | 626.91 Million HKD | 0.15% |
| 2014 Q3 | 626.91 Million HKD | 12.11% |
| 2013 FY | 625.95 Million HKD | 12.25% |
| 2013 Q4 | 625.95 Million HKD | 0.0% |
| 2013 Q1 | 543.06 Million HKD | -2.61% |
| 2013 Q2 | 543.06 Million HKD | 0.0% |
| 2013 Q3 | 625.95 Million HKD | 15.26% |
| 2012 Q4 | 557.63 Million HKD | 0.0% |
| 2012 Q2 | 489.63 Million HKD | 0.0% |
| 2012 Q3 | 557.63 Million HKD | 13.89% |
| 2012 FY | 557.63 Million HKD | -1.0% |
| 2011 Q2 | 451.22 Million HKD | 0.0% |
| 2011 FY | 563.29 Million HKD | 25.2% |
| 2011 Q4 | 563.29 Million HKD | 0.0% |
| 2010 Q2 | 273.7 Million HKD | 0.0% |
| 2010 Q4 | 449.9 Million HKD | 0.0% |
| 2010 FY | 449.9 Million HKD | 67.79% |
| 2009 FY | 268.13 Million HKD | 7.16% |
| 2009 Q4 | 268.13 Million HKD | 0.0% |
| 2009 Q2 | 144.85 Million HKD | 0.0% |
| 2008 FY | 250.22 Million HKD | 2.91% |
| 2008 Q4 | 250.22 Million HKD | 0.0% |
| 2007 FY | 243.14 Million HKD | 0.87% |
| 2006 FY | 241.04 Million HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 308.05 Million HKD | -150.605% |
| Innovative Pharmaceutical Biotech Limited | 1.06 Billion HKD | 27.415% |
| China Overseas Nuoxin International Holdings Limited | 109.1 Million HKD | -607.612% |
| Prosperous Future Holdings Limited | 177.1 Million HKD | -335.897% |
| Huasheng International Holding Limited | 675.58 Million HKD | -14.274% |
| Fourace Industries Group Holdings Limited | 61.8 Million HKD | -1149.109% |
| Evergreen Products Group Limited | 786.46 Million HKD | 1.838% |
| EC Healthcare | 2.97 Billion HKD | 74.009% |
| Blue Moon Group Holdings Limited | 1.61 Billion HKD | 52.281% |
| SuperRobotics Holdings Limited | 172.27 Million HKD | -348.136% |
| Takbo Group Holdings Limited | 42.84 Million HKD | -1701.704% |
| Hyfusin Group Holdings Limited | 181.34 Million HKD | -325.707% |